Chromatin accessibility discriminates stem from mature cell populations, enabling the 42 identification of primitive stem-like cells in primary tumors, such as Glioblastoma (GBM) where 43 self-renewing cells driving cancer progression and recurrence are prime targets for therapeutic 44 intervention. We show, using single-cell chromatin accessibility, that primary GBMs harbor a 45 heterogeneous self-renewing population whose diversity is captured in patient-derived 46 glioblastoma stem cells (GSCs). In depth characterization of chromatin accessibility in GSCs 47 identifies three GSC states: Reactive, Constructive, and Invasive, each governed by uniquely 48 essential transcription factors and present within GBMs in varying proportions. Orthotopic 49 xenografts reveal that GSC states associate with survival, and identify an invasive GSC signature 50 predictive of low patient survival. Our chromatin-driven characterization of GSC states improves 51 prognostic precision and identifies dependencies to guide combination therapies. 52 53 56
INTRODUCTION 54
Glioblastoma (GBM) is a lethal form of brain cancer with standard surgery and radiation giving 55 a median survival of only 12.6 months [1] . The addition of temozolomide chemotherapy provides Government of Ontario for the Brain Cancer Translational Research Initiative. PG was supported 698 by a CIHR Fellowship (MFE 338954) . Funding to HAL and SW was from CIHR. MG holds a Canada 699 Research Chair in Brain Cancer Epigenomics and is supported by CIHR, NSERC and the Alliance 700 for Cancer Gene Therapy. PBD is also supported by CIHR, OICR, the Terry Fox Research Institute, D   G613  G584  G567  G583  G523  G566  G702  G648  G577  G361  G594  G571  G411  G498  G551  G489  G620  G549 
